Tag: Novartis

Novartis building

Novartis on World Malaria Day 2021

Originally published at novartis.com. Novartis Pharmaceuticals is a DiversityInc Hall of Fame company.   The COVID-19 pandemic highlights the importance of robust health systems to respond to disease outbreaks and to control other deadly diseases such as malaria. On World Malaria Day, April 25, we are calling on the global…

Novartis building

Novartis Inaugurates Innovative Watershed Project in India To Increase Water Availability

Originally published at novartis.com. Novartis Pharmaceuticals is a DiversityInc Hall of Fame company.   On World Water Day, Novartis inaugurated an integrated watershed development project to help address water scarcity in the Telangana region of India, one of the world’s most water-stressed countries. Managed jointly with the National Agro Foundation, a…

Novartis building

Novartis CEO Vas Narasimhan Answers COVID-19 Questions

Originally published on LinkedIn.com by Vas Narasimhan.  The top questions I’ve been asked about the pandemic As a physician-scientist who has spent much of my career working on drug and vaccine development, including during the H1N1 pandemic, I’ve been getting many questions about my take on the COVID-19 response. I…

Novartis building

Novartis — Build Trust With Society

Originally published on annualreview.novartis.com. We are making good progress on integrating ethics, access to medicine, global health and corporate responsibility into the core of our business strategy. In 2019, we pursued changes to strengthen governance; took steps to improve decision-making and reinforce our speak-up culture; further integrated access into how…

Novartis building

Novartis — Unleash the Power of Our People

Originally published on annualreview.novartis.com. To help us fulfill our company purpose of reimagining medicine, we are changing the way we work to unleash the talent and creativity of our people. We made progress in 2019 on our cultural transformation, which is a strategic priority for Novartis. We aim to make…

Novartis building

Novartis @ J.P Morgan 2020

Originally published on novartis.com. From January 13th to 16th 2020, Novartis is attending the J.P Morgan Healthcare Conference in San Francisco. This conference is the largest and most informative healthcare investment symposium in the industry, bringing together industry leaders, emerging fast-growth companies, innovative technology creators, and members of the investment…

Novartis building

Amazon Web Services (AWS) announces strategic collaboration with Novartis to accelerate digital transformation of its business operations

Originally published on Novartis.com. We’re collaborating with AWS to build an enterprise-wide data and analytics platform to transform the way medicines are manufactured and delivered. On Wednesday December 4, 2019 Amazon Web Services announced a strategic collaboration with Novartis that will leverage AWS’s broadest portfolio of cloud services to build…

Novartis building

Novartis: Behind the Research Driving Our Data at Medical Conferences

Originally published on novartis.com. Novartis data at 2019 ASH and SABCS underscore our evolving R&D approach in innovative platforms to reimagine medicine and help improve patient outcomes. At the American Society of Hematology (ASH) Annual Meeting & Exposition and the San Antonio Breast Cancer Symposium (SABCS) in December, Novartis will…

Novartis building

Novartis announces new strategy to provide innovative medicines to more patients in sub-Saharan Africa

Originally published on Novartis.com. The strategy is aligned with the Novartis Access Principles, which aim to systematically integrate access strategies in how the company researches, develops and delivers medicines globally A newly formed sub-Saharan Africa unit will deploy innovative approaches to increase patient reach across the full income pyramid Novartis…